Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcranial Magnetic Stimulation (TMS) for Patients With Exposure Therapy-resistant Obsessive-compulsive Disorder (OCD): TETRO - a Multicenter Randomized Controlled Trial

NCT05331937 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT05331937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05331937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcranial Magnetic Stimulation (TMS) for Patients With Exposure Therapy-resistant Obsessive-compulsive Disorder (OCD): TETRO - a Multicenter Randomized Controlled Trial
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Phase 3
Overall status
Recruiting
Start date
May 16, 2022
Completion date
December 1, 2027
Enrollment
250 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

1 hz real rtms to the pre-sma, 1 hz sham rtms to the pre-sma